New York Stem Cell Foundation, Inc.
USPTO PatentsView assignee record - 22 granted patents across 9 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, New ranks #13,574 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 9 technology areas.
- #13,574
- of 49,997 US assignees by volume
- Top 50%
- by Innovation Score (35.2/100)
- 17.8
- avg claims per patent
- +63%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13574 · US Corporation #13,574 · 22 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 22 grants
- MID-PACK #13,574/49,997
- PHOTO-FINISH Nan Juen International
- CPC-NARROW C12N · 9 areas
- INNOV-THIN 35.2/100
- CLAIMS-RICH 17.8 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +63% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Nan Juen International Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How New’s 35.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around New
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- New York Stem Cell… · this assignee
New York Stem Cell… · this assignee
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows New's Innovation Score is 35.2/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for New?
Each dot is one of New’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). New’s own 17.8 claims/patent is ABOVE the 16.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where New's grants concentrate
New York Stem Cell Foundation, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 90.9% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2019 (6 grants) versus a trough of 1 in 2016. By volume, New sits between Nan Juen International Co., Ltd. and Novarad Corporation.
New's three-year grant acceleration
New York Stem Cell Foundation, Inc. shows 6 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at New's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Nan Juen Internat…
Nan Juen International Co., Ltd.
22 patents
- Nanometrics Incor…
Nanometrics Incorporated
22 patents
- Netbase Solutions
NetBase Solutions, Inc.
22 patents
- Neuralink
Neuralink Corp.
22 patents
- Nexenta Systems
Nexenta Systems, Inc.
22 patents
- Next Science IP H…
Next Science IP Holdings Pty Ltd
22 patents
- Ningbo Albert Nov…
Ningbo Albert Novosino Co., Ltd.
22 patents
- Novarad
Novarad Corporation
22 patents
- New York Stem Cel… ◀
New York Stem Cell Foundation, Inc.
22 patents
What this shows New holds 22 patents at rank #13,580, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near New
By rank, the assignees closest to #13,580 in granted patent volume.
- Nan Juen International Co., Ltd. #13,576 · 22 patents
- Nanometrics Incorporated #13,577 · 22 patents
- NetBase Solutions, Inc. #13,578 · 22 patents
- Neuralink Corp. #13,579 · 22 patents
- Nexenta Systems, Inc. #13,581 · 22 patents
- Next Science IP Holdings Pty Ltd #13,582 · 22 patents
- Ningbo Albert Novosino Co., Ltd. #13,583 · 22 patents
- Novarad Corporation #13,584 · 22 patents
Leaders in C12N (Microorganisms OR Enzymes)
Other assignees with the most granted patents in New's primary technology class.
- Monsanto Technology LLC 1,335 in class
- The Regents of the University of California 1,161 in class
- Novozymes A/S 656 in class
- Immatics Biotechnologies GmbH 647 in class
- Pioneer Hi-bred International, Inc. 623 in class
- President and Fellows of Harvard College 594 in class
- Massachusetts Institute of Technology 541 in class
- The Trustees of the University of Pennsylvania 537 in class
New's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 4.5% |
| 2018 | 1 | 4.5% |
| 2019 | 6 | 27.3% |
| 2020 | 1 | 4.5% |
| 2021 | 6 | 27.3% |
| 2022 | 2 | 9.1% |
| 2023 | 3 | 13.6% |
| 2024 | 1 | 4.5% |
| 2025partial year | 1 | 4.5% |
Which technologies does New York Stem Cell Foundation, Inc. patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
New York Stem Cell Foundation, Inc.'s patent record in context - here's where to go next.
- New York Stem Cell Foundation, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 90.9% of its portfolio - see every assignee active in that class. Explore C12N
- Ranked #13,574 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare New York Stem Cell Foundation, Inc. against Nan Juen International Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 35.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.